The preparation and evaluation of xanthinyl analogues as inhibitors of monoamine oxidase B / Kevin Robert Zoellner

Monoamine oxidase B (MAO-B) is a drug target for the treatment of neurodegenerative diseases such as Parkinson's disease. For example, the mechanism-based inactivator of MAO-B, (R)-deprenyl, is frequently used in combination with L-dopa as dopamine replacement therapy in Parkinson's diseas...

Full description

Bibliographic Details
Main Author: Zoellner, Kevin Robert
Published: North-West University 2009
Online Access:http://hdl.handle.net/10394/1382

Similar Items